# Esketamine Combined With Remimazolam on Postoperative Sleep Disturbance and Anxiety in Patients

> **NCT06108830** · NA · RECRUITING · sponsor: **Tianjin Medical University General Hospital** · enrollment: 400 (estimated)

## Conditions studied

- Sleep Disturbance

## Interventions

- **DRUG:** Esketamine
- **DRUG:** Remimazolam
- **DRUG:** Esketamine and remimazolam
- **DRUG:** normal saline

## Key facts

- **NCT ID:** NCT06108830
- **Lead sponsor:** Tianjin Medical University General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-01
- **Primary completion:** 2024-11-30
- **Final completion:** 2024-12-10
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2024-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06108830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06108830, "Esketamine Combined With Remimazolam on Postoperative Sleep Disturbance and Anxiety in Patients". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT06108830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*